Trademark: 79245594
Word
KANGHONG
Status
Registered
Status Code
700
Status Date
Tuesday, October 8, 2019
Serial Number
79245594
Registration Number
5876519
Registration Date
Tuesday, October 8, 2019
Mark Type
3
Filing Date
Tuesday, May 22, 2018
Published for Opposition
Tuesday, July 23, 2019

Trademark Owner History

Classifications
5 Mothproofing preparations; Radioactive substances in the nature of drugs for medical purposes; Chemico-pharmaceutical preparations for reducing blood fat; Chemico-pharmaceutical preparations for promoting sleep; Chemico-pharmaceutical preparations for sedation, anti-depression, tumor suppression; Chemico-pharmaceutical preparations for the treatment of diabetes, diseases of the central nervous system, diseases of the respiratory system, cardiovascular diseases and cancer; Chemico-pharmaceutical preparations used in eye surgery and intraocular surgery; Pharmaceutical preparations in the nature of tissues impregnated with pharmaceutical skin lotions; Depuratives for the body; Media for bacteriological cultures; Medicinal preparations for the mouth to be applied in the form of tablets; Semen for artificial insemination; Medicines for human purposes, namely, medicines for humans for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; Medicines for humans to treat or prevent diabetes, coughs, colds, influenza, headaches and allergic reactions; Vermin destroying preparations; Biochemical drug for medical purposes for the treatment of cancer and ophthalmic diseases; Suppositories; Pharmaceutical preparations in the form of liquids for the treatment of central nervous system diseases, tumors, diabetes, ophthalmic diseases; Pharmaceutical preparations in the form of liquids for the treatment of cancer; Disinfectants for hygiene purposes; Mosquito-repellent incense; Sanitary sterilizing preparations in the nature of tissues impregnated with sterilization preparations; Chemical conductors for electrocardiograph electrodes; Dental lacquer; Medicinal drinks in the nature of herb liqueurs; Pharmaceutical preparations used for the relief of pain and to reduce fever; Pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseases, hemophilia, metabolic diseases, cancer, multiple sclerosis, urologic diseases, sexual dysfunction, osteoporosis, and climacteric diseases; Pharmaceutical preparations, namely, anticoagulants and platelet aggregation inhibitors; anti-infective pharmaceutical preparations; Pharmaceutical preparations, namely, ophthalmics; Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions; Infusions for medical purposes for treating dermatological diseases; Gases for medical purposes; Wadding for medical purposes; Drugs for medical purposes, namely, pharmaceutical preparations for anti-depression, tumor suppression, relieving cough, reducing blood pressure; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment central nervous system diseases, asthma, diabetes, respiratory system diseases, cancer, cardiovascular diseases, gastrointestinal diseases, hyperlipidaemia and hypercholesteremia; Drugs for medical purposes, namely, pharmaceutical preparations used in eye surgery and intraocular surgery; Bath preparations for medical purposes; Diagnostic agents for medical purposes; Solutions for contact lenses; Crude drugs, namely pharmaceutical preparations for the treatment of central nervous system diseases, namely hypertension, hyperlipidemia, schizophrenia and melancholia, digestive system diseases, namely dyspepsia, chronic gastritis, chronic lithogenous cholecystitis, chronic cholecystitis and gall-stone, ophthalmology system diseases, namely wet Age-related Macular Degeneration (AMD), and other diseases, namely fever, irritability, red eyes, mouth sores, sore throat, swollen gums, constipation, pharyngitis, tonsillitis, gingivitis, upper respiratory infection (URI), acute bronchitis, diabetes and nephropathy; Pharmaceutical preparations in the form of injections for the treatment of central nervous system diseases, diabetes, fundus oculi disease and cancer; Pharmaceutical preparations in the form of injections for tumor suppression; Pharmaceutical preparations in the form of injections used in eye surgery and intraocular surgery; Traditional Chinese medicines for Chinese medicinal use, namely, dried Chinese boxthorn fruits, Chinese-date, pseudo-ginseng, Chinese angelica and ginseng; Traditional Chinese medicines for Chinese medicinal use, namely, dried Chinese boxthorn fruits, Chinese-date, pseudo-ginseng, Chinese angelica and ginseng sold as a kit in a Chinese medicine bag
The mark consists of of a rounded chevron inside of a rectangle with rounded corners. To the right are two Chinese characters with a line underneath and the wording "KANGHONG" underneath the line.
The non-Latin characters in the mark transliterate to "KANG HONG" and this has no meaning in a foreign language.
KANG HONG
Color is not claimed as a feature of the mark.
THE CHINESE CHARACTER THAT TRANSLITERATES TO "KANG"

Trademark Events
Nov 27, 2018
Application Filing Receipt Mailed
Nov 22, 2018
Sn Assigned For Sect 66a Appl From Ib
Nov 23, 2018
New Application Office Supplied Data Entered
Nov 23, 2018
Assigned To Examiner
Nov 29, 2018
Non-Final Action Written
Nov 30, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Dec 13, 2018
Refusal Processed By Mpu
Dec 13, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Dec 28, 2018
Refusal Processed By Ib
May 9, 2019
Teas Response To Office Action Received
May 9, 2019
Correspondence Received In Law Office
May 10, 2019
Teas/Email Correspondence Entered
May 31, 2019
Approved For Pub - Principal Register
Jun 14, 2019
Assigned To Lie
Jul 3, 2019
Notification Of Notice Of Publication E-Mailed
Jul 23, 2019
Published For Opposition
Jul 23, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 8, 2019
Registered-Principal Register
Jan 8, 2020
Final Disposition Notice Created, To Be Sent To Ib
Feb 3, 2020
Generic Madrid Transaction Created
Feb 10, 2022
Teas Change Of Owner Address Received
Feb 10, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 10, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 10, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 10, 2022
Teas Change Of Correspondence Received
Jun 9, 2024
New Representative At Ib Received
Feb 3, 2020
Generic Madrid Transaction Sent To Ib
Mar 13, 2020
Final Decision Transaction Processed By Ib
Feb 10, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered

Trademark Alertz updated from USPTO on 2030-01-24